Active	Status	Sponsor type	Region	Phase	Filter
11 Active 14 Inactive 25 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Vitolo, Umberto
BRUIN-CLL-314, NCT05254743 / 2021-003206-41: A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)	Active, not recruiting	3	650	Europe, Canada, Japan, US, RoW	Pirtobrutinib, LOXO-305, LY3527727, Ibrutinib	Loxo Oncology, Inc., Eli Lilly and Company	Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma	06/25	01/28
NCT05365659: IKS03 in Patients with Advanced B Cell Non-Hodgkin Lymphomas	Recruiting	1	140	Europe, Canada, US, RoW	IKS03	Iksuda Therapeutics Ltd.	B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, B-cell Lymphoma	09/25	09/27
Biancone, Luigi
VARVARA, NCT05907096: ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function	Recruiting	2	102	Europe, Canada, US, RoW	ARGX-117, Placebo	argenx	Delayed Graft Function	04/26	12/26
Priolo, Giorgio
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Vitolo, Umberto
BRUIN-CLL-314, NCT05254743 / 2021-003206-41: A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)	Active, not recruiting	3	650	Europe, Canada, Japan, US, RoW	Pirtobrutinib, LOXO-305, LY3527727, Ibrutinib	Loxo Oncology, Inc., Eli Lilly and Company	Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma	06/25	01/28
NCT05365659: IKS03 in Patients with Advanced B Cell Non-Hodgkin Lymphomas	Recruiting	1	140	Europe, Canada, US, RoW	IKS03	Iksuda Therapeutics Ltd.	B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, B-cell Lymphoma	09/25	09/27
Biancone, Luigi
VARVARA, NCT05907096: ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function	Recruiting	2	102	Europe, Canada, US, RoW	ARGX-117, Placebo	argenx	Delayed Graft Function	04/26	12/26
Priolo, Giorgio
No trials found